Pharmacy Service, Durham VA Medical Center, Durham, NC 27705, USA.
Reprod Sci. 2013 Jul;20(7):739-44. doi: 10.1177/1933719112466304. Epub 2012 Nov 30.
Male infertility is a relatively common condition caused by low sperm production, immobile sperm, or blockages that prevent the delivery of sperm. This condition can be caused by a variety of illnesses, injuries, chronic health problems, lifestyle choices, other factors, or idiopathic, in which abnormal semen parameters occur without an identifiable cause. Medical management traditionally focuses on correcting endocrine abnormalities related to hormone deficiencies. Clomiphene citrate is an antiestrogen thought to increase sperm parameters in males attempting to conceive. The objective of this review was to evaluate the efficacy and safety of clomiphene citrate in the treatment of male patients with infertility. A literature search of MEDLINE (1966-June 2012) and EMBASE (1980-June 2012) was conducted using the medical terms clomiphene and male infertility and 9 clinical studies were identified. Overall, only 1 study detected a statistically significant benefit on the pregnancy rate in the clomiphene group; however, the majority of the studies demonstrated a statistically significant increase in sperm concentrations. At doses used to treat male infertility, clomiphene was well tolerated with no identified serious adverse effects. Based on the reviewed studies there is insufficient evidence to indicate that clomiphene is effective for the treatment of male infertility.
男性不育症是一种较为常见的病症,其病因包括精子生成量低、精子活动力差或输送精子的通道受阻。这种病症可能由多种疾病、损伤、慢性健康问题、生活方式选择、其他因素或特发性因素引起,后者是指精液参数异常但没有明确病因。医学治疗通常侧重于纠正与激素缺乏相关的内分泌异常。枸橼酸氯米酚是一种抗雌激素药物,被认为可以增加尝试受孕的男性的精子参数。本综述的目的是评估枸橼酸氯米酚治疗男性不育症患者的疗效和安全性。我们使用医学术语枸橼酸氯米酚和男性不育症对 MEDLINE(1966 年至 2012 年 6 月)和 EMBASE(1980 年至 2012 年 6 月)进行了文献检索,共确定了 9 项临床研究。总体而言,只有 1 项研究发现枸橼酸氯米酚组的妊娠率有统计学意义上的显著提高;然而,大多数研究显示精子浓度有统计学意义上的显著增加。在用于治疗男性不育症的剂量下,枸橼酸氯米酚耐受良好,未发现严重不良影响。根据已审查的研究,没有足够的证据表明枸橼酸氯米酚对男性不育症的治疗有效。